Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021226

KALETRA (LOPINAVIR; RITONAVIR)
133.3MG;33.3MG Marketing Status: Discontinued

Active Ingredient: LOPINAVIR; RITONAVIR
Proprietary Name: KALETRA
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 133.3MG;33.3MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N021226
Product Number: 001
Approval Date: Sep 15, 2000
Applicant Holder Full Name: ABBVIE INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English